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RESULTS
Identification of mutations in PLK4 and TUBGCP6
We ascertained a consanguineous family with seven affected individuals with microcephalic dwarfism from the Khyber Pakhtunkhwa (KPK) province of Pakistan (Fig. 1a , Table 1 and Supplementary  Table 1 ). Genome-wide linkage studies on this family by Illumina BeadChip SNP genotyping established a new disease-associated locus of 11.7 Mb comprising 56 genes on chromosome 4 with a statistically significant logarithm of odds (LOD) score of z = 4.7 ( Supplementary  Fig. 1a,b) . Exome sequencing of one affected individual from this family identified a homozygous intronic mutation, c.2811-5C>G, in PLK4 (encoding Polo-like kinase 4), which was subsequently confirmed by capillary sequencing in this and other affected family members. This mutation was predicted to create a new splice acceptor site in intron 15, incorporating 4 bp of intronic sequence into the transcript and causing a frameshift and premature truncation of the protein (p.Arg936Serfs*1) ( Table 1 ). The variant was not present in 286 Pakistani controls or in the 1000 Genomes Project and National Heart, Lung, and Blood Institute Grand Opportunity (NHLBIGO) Exome Sequencing Project (ESP) public variant databases.
Independently, exome sequencing was also performed on a 15-yearold African case with extreme microcephaly, short stature, retinopathy and deafness (subject P6; Table 1 ). After filtering for common variants (minor allele frequency (MAF) > 0.005), analysis under a recessive model of inheritance identified a homozygous frameshift mutation in exon 5 of PLK4 (c.1299_1303delTAAAG; p.Phe433Leufs*6), which was confirmed by capillary sequencing ( Table 1 ) and was not detected in 364 control chromosomes. Additionally, this variant was not present in the 1000 Genomes Project database and was reported in the ESP database with an allele frequency of 0.00016, in keeping with it being a causative mutation for a rare recessive disorder.
Capillary resequencing of the coding exons and splice-site junctions of PLK4 in 318 primary microcephaly and primordial dwarfism cases led to the identification of a second individual homozygous for the c.1299_1303delTAAAG mutation. Strikingly, the two cases were from entirely distinct geographical regions: P6 was from Madagascar and P7 was from Iran. However, microsatellite genotyping of the region surrounding PLK4 identified an ancestral haplotype shared by both cases, extending 2.9 Mb from 126.3 to 129.2 Mb on chromosome 4 (hg19) (Supplementary Fig. 1c) , consistent with shared remote ancestry many generations ago.
As PLK4 is a key regulator of centriole biogenesis 12, 13 and given the genetic mapping data identifying distinct, independent mutations predicted to substantially disrupt gene function, we concluded that PLK4 was a newly discovered disease-related gene.
Phenotypically, the individuals with PLK4 mutations displayed profound microcephaly (head circumference, −11.6 ± 2.7 s.d.) and substantial growth retardation of prenatal onset, with markedly reduced height (−5.5 ± 2.1 s.d. at current age), in keeping with the diagnosis of microcephalic primordial dwarfism (Fig. 1a-c , Table 1 and Supplementary Table 1) on the primary microcephaly-Seckel syndrome spectrum 14 . Severe intellectual disability was evident in all cases, and in some individuals there were additional neurological deficits (Supplementary Note). Neuroimaging demonstrated marked reduction in cortical size with simplified gyral folding (Fig. 1d) . Cerebellar and brain stem size were also reduced, with collections of increased cerebrospinal fluid evident, particularly in P2 and P7 in whom large interhemispheric arachnoid cysts were seen ( Supplementary Fig. 2 ).
Ocular anomalies were also frequently observed. In family 1, eye size was reduced in some affected individuals, most prominently in P4 who had the complete absence of one eye (magnetic resonance imaging (MRI); Supplementary Fig. 2c ). In P6, the results from detailed ophthalmological assessment were available: fundus examination showed pale optic discs, thin retinal vessels and bilateral macular atrophy. The electroradiogram (ERG) was non-recordable, reflecting a severe generalized retinopathy. Subsequent exome sequencing of an unrelated individual with primordial dwarfism and retinopathy identified a homozygous frameshift mutation in TUBGCP6 (c.4333insT; p.His1445Leufs*24). In this individual, the ERG also demonstrated the complete absence of rod and cone function. Notably, TUBGCP6 is a direct phosphorylation target of the PLK4 kinase 15 , suggesting that these proteins might act in the same cellular pathway to cause the microcephaly and retinopathy phenotypes. Subsequent screening of 12 additional individuals with microcephaly and retinal dystrophy identified 3 further cases with TUBGCP6 mutations, all of whom were phenotypically similar to the As with family 1, micropthalmia was also seen in family 6. Identification of these mutations substantiates a previous case report of microcephaly and chorioretinopathy in an Amish individual for whom a homozygous TUBGCP6 mutation disrupting the termination codon was detected by exome sequencing 16 . Given the previous publication on TUBGCP6, we focused subsequent investigations on the functional consequences of mutations in PLK4 because of its central importance in centriole biogenesis 12, 13 and the availability of primary cell lines from individuals with PLK4 mutations.
Transcriptional and protein consequences of the PLK4 mutations
In family 1, the c.2811-5C>G mutation was predicted to create a new splice acceptor site, resulting in the addition of 4 bp of the Age is shown in years at the time of the measurements. OFC, occipitofrontal circumference; s.d., standard deviation from the population mean; ss, splice site created by mutation; CNS, central nervous system; CHD, congenital heart disease; NA, not available. The OFC for P9 was determined at 9 years of age. 
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A r t i c l e s intron 15 sequence to the transcript and premature truncation of the PLK4 protein in the last polo-box domain (Fig. 2a,b) . RT-PCR confirmed that this mutation altered splicing (Fig. 2c) , with no residual wild-type transcript detectable in RNA from the affected individual ( Supplementary Fig. 3a) .
In families 2 and 3, the homozygous c.1299_1303delTAAAG mutation in exon 5 of PLK4 (Fig. 2a,b ) resulted in a frameshift introducing an early termination codon (p.Phe433Leufs*6), predicted to result in complete abrogation of protein function, as key functional domains are lost. As Plk4 is essential for mouse embryonic development 17 , this finding was surprising and prompted further investigation. Splice-site prediction (Alamut, Interactive Biosoftware) identified an alternative splice donor site 42 bp upstream of the deletion, and we therefore postulated that alternative splicing might partially rescue PLK4 function, with use of this splice donor site bypassing the deletion and leading to an in-frame loss of 60 amino acids (Fig. 2a,b) . To confirm the existence of this alternative transcript in humans, we performed RT-PCR with primers mapping to exons 5 and 6 whose product spanned the alternative and known splice donor sites in exon 5. Both spliced forms (henceforth denoted full length (FL) and alternate (ALT), respectively) were detected ubiquitously in adult tissues, fetal brain, retina and neural progenitor stem cells (Supplementary Fig. 4a ). Capillary sequencing of RT-PCR products confirmed the predicted splicesite junctions of the ALT and FL transcripts ( Supplementary  Fig. 4b) . Notably, the alternative splice site was only present in apes and was not found in other primates, as a single-nucleotide substitution at this site results in a derived allele that creates a consensus splice-site sequence (Supplementary Fig. 4c ). Experimentally, RT-PCR of plk4 in other vertebrates detected only one transcript, establishing that alternative splicing of this region of exon 5 is specific to humans and apes (Fig. 2d) .
The identification of an alternative transcript encoding an internal 60-residue deletion that lay outside of a known functional domain suggested that the 5-bp deletion would lead to reduced PLK4 activity rather than complete loss of PLK4 function. To address this possibility, we first investigated the effect of this mutation on transcript levels by quantitative RT-PCR of PLK4 (ALT) and PLK4 (FL). As anticipated, PLK4 (FL) transcript levels were substantially reduced ( Supplementary Fig. 5a ), consistent with nonsense-mediated decay of the prematurely terminating transcript. In contrast, PLK4 
(ALT) was stably expressed in patient-derived cells ( Supplementary  Fig. 5b ), such that the total amount of PLK4 transcript available to produce functional PLK4 enzyme in these cells was reduced to 25.7 ± 2.8% of control levels ( Fig. 2e) . We next determined the consequences of the p.Arg936Serfs*1 and p.Phe433Leufs*6 alterations on the PLK4 protein in three patientderived cell lines. Immunoblotting was performed to characterize the effects of the mutations on the cellular levels of the PLK4 protein. Two PLK4-specific bands were evident in immunoblotting with a published antibody to PLK4 (ref. 18) (Fig. 2f) , corresponding to the FL and ALT isoforms. In fibroblasts derived from P6 and P7, the slower-migrating band was absent, consistent with loss of the FL isoform from these cells. The intensity for the band in P1-derived fibroblasts was markedly reduced and the band appeared to have increased mobility relative to the FL band, in keeping with reduced protein size due to the C-terminal truncation. Additionally, we measured PLK4 accumulation at the centrosome by immunofluorescence (Fig. 2g and Supplementary Figs. 6 and 7) . As the immunofluorescence signal in primary fibroblasts was too weak to quantify, we treated cells with the proteasomal inhibitor MG132 before fixation to enhance PLK4 detection, permitting robust, reproducible measurements. Quantitative analysis of the immunofluorescent signal established that PLK4 levels were significantly reduced (P < 0.0001), with PLK4 protein levels 15 ± 0.02%, 36 ± 1% and 42 ± 0.08% of control levels in fibroblasts derived from P1, P6 and P7, respectively (Fig. 2g) .
We concluded that both mutations result in reduced levels of PLK4 protein in the cell. For the p.Phe433Leufs*6 alteration (P6 and P7), this occurs as the consequence of nonsense-mediated decay of the FL transcript and consequent loss of the FL protein. For the p.Arg936Serfs*1 alteration (P1), the frameshift occurs in the terminal exon, so nonsense-mediated decay would not be expected. However, structural modeling of the terminal polo-box domain (PB3) indicated that this domain would be substantially disrupted in the mutant protein (Supplementary Fig. 3b) . Therefore, the marked reduction in protein levels in these cells is likely due to a consequent reduction in protein stability.
PLK4 mutations impair centriole biogenesis
We assessed the functional activity of both full-length isoforms and mutant PLK4 proteins using an overexpression assay 19 . Enzyme activity, determined by the overduplication of centriole number, was significantly impaired for both mutant proteins, indicating that such residual mutant protein would also be functionally impaired (Fig. 3a,b and Supplementary Fig. 8 ). In contrast, the PLK4 (ALT) protein was as active as PLK4 (FL), consistent with a similar functionality in centriole duplication.
Given the consequences of the mutations on PLK4 transcript and protein, centriole duplication would be predicted to be impaired but not absent in cells derived from affected individuals. As centriole number changes over the course of the cell cycle, mitosis provides a convenient stage to quantify centriole number, with four centrioles normally present at this time. In keeping with their reduced PLK4 function, patient-derived fibroblasts had a statistically significant reduction in centriole number, with the number of prometaphase (Fig. 3d) .
As centrioles are key centrosomal components, centriolar depletion would be expected to impair mitotic spindle formation. Accordingly, normal mitotic spindle formation was affected in patient-derived cells with reduced centriole number, with monopolar spindles most frequently observed (Fig. 3e) . Delayed mitotic progression would therefore be predicted in these cells, as a balanced bipolar spindle is required for efficient mitosis 20 . At least some of these cells eventually progressed through mitosis, as anaphase cells with a single centriole pair were observed (data not shown) and an increase in the number of interphase cells without centrioles was seen (P6, 3.9%, P = 0.03; P7, 2.5%, P = 0.01; Supplementary Fig. 9 ). Abnormalities in the mitotic spindle can lead to mitotic errors, including chromosome segregation defects, cytokinesis failure or cell death. However, no significant increase in the number of cells with >4N DNA content was observed by FACS analysis (data not shown), nor was increased cell death detected by Annexin V staining (Supplementary Fig. 10) . Additionally, chromosome segregation errors during anaphase were rarely observed (Supplementary Table 2) , and interphase FISH also did not demonstrate a significant increase in aneuploidy or tetraploidy (Supplementary Fig. 11) .
We therefore concluded that reduced PLK4 activity results in impaired centriolar duplication and leads to impaired mitotic spindle formation in a subset of cells. To address the developmental consequences of such cellular PLK4 dysfunction, we next established a zebrafish model.
plk4 depletion impairs mitosis and reduces zebrafish size
As our cellular studies established that mutations reduced PLK4 levels, we used morpholino antisense oligonucleotides to deplete plk4 transcripts in zebrafish, a system previously used to model primordial dwarfism due to mutations in ORC1 (ref. 21) . We designed splice siteblocking morpholinos to target the splice donor and acceptor sites of exon 5 of zebrafish plk4 (Fig. 4a) . Titration of pooled morpholino oligonucleotides injected into embryos at the one-cell stage permitted depletion of plk4 transcript to 2-25% of control levels in embryos at 1 day post-fertilization (d.p.f.) (Fig. 4b) , with 0.5 ng of plk4 morpholino achieving transcript levels comparable to those seen in fibroblasts derived from the individuals with PLK4 mutations (Fig. 2e) . Overall body size was significantly reduced in plk4 morphants at 5 d.p.f. (Fig. 4c,d and Supplementary Fig. 12) , with reduction in size correlating with the extent of transcript depletion (Fig. 4d) . Reduction in embryo size was a consequence of reduced cell number (Fig. 4e) , with cell size remaining unchanged (Supplementary Fig. 13) . Such reduction in cell number was evident from early on in development (Fig. 4e) and could be the consequence of reduced cell proliferation or increased cell death. Reduced growth was a direct effect of plk4 depletion rather than morpholino-induced toxicity, as growth was rescued by coinjection of embryos with 150 pg of zebrafish plk4 mRNA and 1.5 ng of plk4 morpholino (P < 0.05; Fig. 4d ). When human PLK4 (FL) and PLK4 (ALT) mRNAs were used for coinjection, both partially rescued the dwarfism phenotype, indicating that both isoforms can functionally contribute to organism growth (Fig. 4f) , whereas PLK4 mRNAs encoding the Arg936fs*1 and Phe433Leufs*6 mutants both failed to rescue the aberrant growth phenotype.
To gain insight into the mechanism underlying reduced growth and cell number, we disaggregated plk4 morpholino-injected zebrafish embryos and examined embryonic cells by immunofluorescence and FACS analysis. Immunostaining for centrin-3 established that reduced plk4 levels also impaired centriolar biogenesis during development, with the majority of mitotic cells having fewer than the expected four centrioles (65% of mitotic cells in plk4 morphants versus 7% in control embryos; P = 0.0004; Fig. 5a ). We postulated that cell cycle progression would consequently be impaired, so we next performed FACS cell cycle analysis, which demonstrated a significant accumulation of cells positive for phosphorylated histone H3 in plk4 morphants (3.9% of cells versus <0.56% in controls; P < 0.05; Fig. 5b) . Given the reduced cell proliferation in plk4 morphants (Fig. 4e) , this finding indicates a substantial delay in mitotic progression, also seen in stil-mutant zebrafish 22 , which likely occurs as a consequence of aberrant mitotic spindle formation (Fig. 5c) resulting from impaired centriole duplication. Spindle formation might additionally be compromised because of the role of Plk4 in acentriolar spindle formation 23 . An increased rate of apoptosis has been observed for other centriole biogenesis mutants 22, [24] [25] [26] , and we therefore also performed TUNEL staining (Supplementary Fig. 14) . A low level of apoptosis was seen in zebrafish injected with 0.5 ng of plk4 morpholino, and the level increased at higher doses of morpholino, suggesting that cell death also contributes to the decrease in cell number in these embryos, although TUNEL-positive cells were often localized to the tail region and did not precisely correlate with the broad increase in the number of cells with positive staining for phosphorylated histone H3. Furthermore, unlike the partial rescue seen in stil-mutant zebrafish with tp53 depletion 22 , no rescue in growth was seen in tp53-mutant zebrafish injected with plk4 morpholino (Supplementary Fig. 15 ).
Photoreceptor and ciliopathy phenotypes in plk4 morphants
Retinopathy occurs in individuals with mutations in either PLK4 or TUBGCP6 (Table 1) , and, therefore, we next used our plk4-morphant model to investigate the basis of this phenotype. We found that plk4-morphant zebrafish had impaired responses to visual stimuli, with 60% having impaired light-dark adaption, even at low (0.5 ng) levels of morpholino (Fig. 6a) . Immunohistological examination of the eyes demonstrated loss of photoreceptors, using antibody to zpr-1 as a marker 27 , as well as a variable reduction in eye size (Fig. 6b) , consistent with the ophthalmological findings observed in humans with PLK4 and TUBGCP6 mutations. As cilia are key structures in the photoreceptors required for outer segment structure and function 28 , we performed immunostaining of cilia axonemes and basal bodies ( Fig. 6c and Supplementary Fig. 16 ). This analysis demonstrated reduced numbers of cells containing cilia in the photoreceptor layer, with an absence of basal bodies correlating with the absence of cilia. Cilia loss was a direct effect of plk4 morpholino rather than morpholino-induced toxicity, as it could be rescued by coinjection of embryos with PLK4 mRNA (Fig. 6c) .
Additional cilia-related phenotypes were observed upon injection with higher doses of plk4 morpholinos, as previously observed with cep152-depleted zebrafish 29 . Notably, these phenotypes were separable from the growth phenotype in a dose-dependent manner, with injections of 0.5 ng of plk4 morpholino resulting in small but structurally normal fish, whereas, at 1.5 ng and 3 ng, embryos with ciliopathyassociated phenotypes were generated, including hydrocephalus, renal cysts and ventral curvature (Fig. 7a-d) . Furthermore, left-right asymmetry defects were detectable upon injecting plk4 morpholino into a transgenic reporter line Tg(bre-aavmlp:egfp) that labels heart musculature ( Fig. 7c) , and quantification of motile cilia in Kupffer's vesicle demonstrated a significant decrease in the proportion of cells with cilia in embryos injected with 3 ng of plk4 morpholino (Fig. 7d) . Likewise, the number of ciliated cells was also decreased in serumstarved fibroblasts derived from affected individuals ( Supplementary  Fig. 17) . As many cells in embryos injected with plk4 morpholino had no remaining centrioles (25% had no centrioles, 38% had one centriole and 30% had two centrioles) and cilia loss correlated with the absence of basal bodies in cells derived from affected individuals, we concluded that the cilia phenotype was likely directly attributable to the absence of basal bodies. 
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DISCUSSION
Here we identify mutations in PLK4 and TUBGCP6 in microcephalic dwarfism and using cellular and developmental systems establish that, through reduction in centriole number, PLK4 mutations result in aberrant growth and retinal phenotypes. The microcephaly and short stature seen in individuals with mutations in PLK4 and TUBGCP6 are comparable to the characteristics seen with previously reported mutations in centriolar biogenesis genes [8] [9] [10] [11] . However, additional developmental anomalies are also apparent, most prominently, a generalized retinopathy that has not been reported with other genes involved in primary microcephaly and Seckel syndrome. Although retinopathy is a consistent feature in individuals with TUBGCP6 mutations, it remains to be established whether it is an invariant feature in individuals with PLK4 mutations, as the geographical remoteness of families 1 and 3 precluded detailed ophthalmological assessment and electroretinography. Mutations in the mitotic spindle-binding motor kinesin gene KIF11 also cause microcephaly and retinopathy, but this phenotype is dominantly inherited, manifesting as chorioretinopathy and retinal folds 30 , seemingly distinct from the retinopathy reported here. TUBGCP6 is a direct phosphorylation target of PLK4 and so might define a new pathway with specialized function in photoreceptors. Alternatively, the retinal pathology might result from perturbed mitosis in the eye 31 or impaired cilia formation, given the loss of photoreceptor cilia in the plk4-morphant zebrafish model.
Although the biology of PLK4 has been intensively studied in recent years 32 , the early embryonic lethality of the Plk4 −/− mouse 17 has limited developmental studies in mammals. Plk4 +/− mice have not been reported to have microcephaly or reduced body size but were found to exhibit increased rates of liver and lung cancer 33 . Although increased genome instability was thought to be due to cellular centrosome amplification and increased levels of tetraploidy, more recent studies on the same Plk4 +/− embryonic fibroblasts did not demonstrate centrosome amplification or aneuploidy 34 . Additionally, centrosomal PLK4 protein levels were normal, despite a 50% decrease in transcript levels in Plk4 +/− cells, explained by the ability of PLK4 to regulate its own stability through autophosphorylation of a phosphodegron 35 . In contrast, in cells derived from individuals with PLK4 mutations, a npg more substantial decrease (75%) in transcript levels impairs protein function, resulting in reduced centriole duplication. Therefore, human PLK4 mutations appear to result in protein levels that fall into a narrow window where autoregulation fails to fully compensate but the protein retains sufficient enzyme activity to prevent lethality (Fig. 7e) . A single pair of centrioles at one spindle pole is most frequently seen in mitotic cells derived from individuals with PLK4 mutations, suggesting that, when centriole duplication fails, the centrosome remains a highly stable structure. Acting as a single microtubular organizing center, this centriole generates a monopolar spindle 12 , delaying mitotic progression. Such a configuration might be more challenging for mitosis even than acentriolar spindle assembly; however, such mitoses can successfully resolve, as cells derived from affected individuals are seen without any centrioles (Supplementary Fig. 9 ). This resolution of mitosis likely occurs through the eventual formation of a bipolar spindle to permit chromosome segregation 34 . Although only a proportion of mitoses are affected (Fig. 3) , during development, most cells from affected individuals would be expected to encounter monopolar spindle formation at some point over successive rounds of cell division. Such a reduction in mitotic and cell cycle efficiency could consequently be sufficient to cause substantial dwarfism over the ~46 cell divisions required to produce the 1 × 10 14 cells of the human body. As mitotic delay can also promote cell death 25 , this might also contribute to reduced organism size through the depletion of cell number. Indeed, p53-mediated apoptosis resulting from mitotic arrest occurs in stil-mutant zebrafish and Cenpj −/− mice 22, 25 . Increased apoptosis is also seen in plk4-morphant zebrafish embryos; however, as embryonic growth in plk4 morphants was not rescued in the tp53-null background, this finding suggests that additional pathways contribute to cell death in the absence of normal centrosome numbers.
Why mutations in PLK4 (and other centrosomal genes related to primary microcephaly and Seckel syndrome) have a disproportionate effect on brain size remains an important unanswered question, particularly as all are ubiquitously required for cell division. It may be that the specific requirement for the coordination of symmetric and asymmetric cell divisions in neural progenitor cells 36 is disrupted in individuals with PLK4 mutations owing to abnormal spindle assembly. Alternatively, mitotic progression might be disproportionately impaired in neuroepithelial tissues 31 , given the high rates of proliferation in neurogenesis, a process that occurs during a restricted developmental time frame. Additionally, aberrant mitosis might itself promote cell death within the mammalian brain 37 . Furthermore, in this respect, monopolar spindle formation can predispose to chromosome segregation failure 38 , and, although substantial levels of aneuploidy were not detected in fibroblasts derived from individuals with PLK4 mutations, microcephaly can result from aneuploidy occurring during neurogenesis 39, 40 .
Cilia phenotypes were only seen in zebrafish embryos with substantial depletion of plk4, accompanied by a marked reduction in body size. Extrapolating to human development, this observation might explain why cilia and growth defects have not been reported, as more extreme intrauterine growth restriction is unlikely to be viable. Separation of the ciliopathy and growth phenotypes is likely explained by the different sensitivity of mitosis and ciliogenesis to impaired centriole duplication. Reduced centriole number will result in monopolar spindle formation, disrupting mitosis, whereas ciliogenesis might continue, with cilia loss only occurring when no centrioles remain, as a single centriole may be sufficient to generate a cilium 41 . However, many mitoses in cells from individuals with PLK4 mutations have two centrioles at one pole and none at the other, and it is therefore more likely that the proportion of ciliated cells is reduced in a dosedependent manner, with cilia-dependent phenotypes only appearing when a critical level is reached (Fig. 7f) . Some decrease in the ciliation of fibroblasts from affected individuals is seen, but this loss seems to be tolerated developmentally, as there is a general absence of ciliopathy phenotypes in the corresponding individuals. Notably, a 100-fold reduction in cilia levels is needed to impair nodal flow and perturb left-right asymmetry in mouse embryos 42 , demonstrating that developmental processes can be highly tolerant of reduced cilia number.
Given the essential role of centrioles during mammalian development 24 , the presence of truncating mutations in centriole biogenesis genes [8] [9] [10] [11] is surprising. Our identification of an alternative isoform that partially rescues PLK4 activity in the face of an intragenic frameshift deletion reconciles this disparity, at least for this gene. It will be of interest to determine how centriole duplication is maintained with null mutations in other genes involved in centriolar biogenesis.
In summary, we report that mutations in PLK4 and TUBGCP6 cause microcephalic primordial dwarfism and a generalized retinopathy, extending the phenotype spectrum associated with centriole biogenesis genes, identifying a new biological pathway for retinal dysfunction and establishing that PLK4 activity is differentially required for growth and cilia-dependent processes during development. 
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ONLINE METHODS
Research subjects. Genomic DNA from the affected children and family members was extracted from peripheral blood using standard methods or saliva samples using Oragene collection kits according to the manufacturer's instructions. Informed consent was obtained from all participating families, and the studies were approved by the ethics review board at the National Institute for Biotechnology and Genetic Engineering in Faisalabad, Pakistan, and the Scottish Multicentre Research Ethics Committee (04:MRE00/19). Parents provided written consent for the publication of photographs of the affected individuals.
Exome capture and sequencing. Whole-exome capture and sequencing was performed at CCG and at the Wellcome Trust Sanger Institute (WTSI). At WTSI, DNA was sheared to 150-bp fragments by sonication (Covaris) before whole-exome capture and amplification using the SureSelect Human All Exon 50Mb kit (Agilent Technologies). Fragments were sequenced using an Illumina HiSeq instrument. We aligned the 75-bp paired-end sequence reads to the Genome Reference Consortium human Build 37 reference sequence using the Burrows-Wheeler Aligner (BWA) 43 . Single-nucleotide variants were called using GATK and SAMtools, and indels were called using Dindel and SAMtools. Variants were annotated with functional consequence using the Ensembl Variant Effect Predictor 44 . Allele frequencies from the 1000 Genomes Project 44 database were used to filter out population variants. Data sets were analyzed under a model of autosomal recessive inheritance. At CCG, DNA (1 µg) was fragmented using sonication technology (Covaris). Fragments were enriched using the SeqCap EZ Human Exome Library v2.0 kit (Roche NimbleGen) and subsequently sequenced on an Illumina HiSeq 2000 sequencing instrument using a paired-end 2 × 100-bp protocol. This sequencing generated 8.4 Gb of mapped sequences with a mean coverage of 89-fold, a 30× coverage of 87% of the target sequences and a 10× coverage of 97% of the target sequences. For data analysis, the Varbank pipeline v.2.3 and filter interface was used. Primary data were filtered according to signal purity by Illumina Real-Time Analysis (RTA) software v1.8. Subsequently, the reads were mapped to the human genome reference build hg19 using the BWA 43 alignment algorithm. GATK (v1.6) 45 was used to mark duplicated reads, perform local realignment around short insertions and deletions, recalibrate the base quality scores, and call SNPs and short indels.
Scripts developed in house at CCG were applied to detect protein changes, affected donor and acceptor splice sites, and overlaps with known variants. Acceptor and donor splice-site mutations were analyzed with a maximumentropy model 46 and filtered for changes in effect. In particular, we filtered for high-quality (coverage > 15; quality > 25), rare (MAF < 0.005) homozygous variants (dbSNP Build 135, 1000 Genomes Project database build 20110521 and the public Exome Variant Server, NHLBI ESP, Seattle, build ESP6500). We also filtered against an in-house database containing variants from 511 exomes for individuals with epilepsy to exclude pipeline-related artifacts (MAF < 0.004). We validated the variants of the highest priority by conventional Sanger sequencing.
Capillary sequencing. Primers were designed to amplify all exons and exonintron boundaries of PLK4 and TUBGCP6 (Supplementary Table 3a) . Genomic DNA from cases and parents (when available) was amplified, and PCR products underwent capillary sequenced on an ABI 3730 capillary sequencer. Sequence traces were analyzed using Mutation Surveyor software (SoftGenetics).
SNP and microsatellite genotyping. Eight individuals of family 1 from Pakistan were genotyped on an Illumina HumanCoreExome-12 v1.1 BeadChip (Supplementary Fig. 1 ; IV-1 (MCP68-5), IV-16 (MCP68-7), IV-17 (MCP68-9), V-1 (MCP68-13), V-2 (MCP68-14), V-3 (MCVP68-10), VI-2 (MCP68-11) and VI-1 (MCP68-12) ). Genome-wide linkage analysis of the family was performed with 24,209 selected SNP markers. LOD scores were calculated with ALLEGRO 47 . Data handling, evaluation and statistical analysis were performed as described previously 48 .
The microsatellites present in a 14.2-Mb region flanking PLK4 were identified from public sequence databases, amplified from genomic DNA by PCR using fluorescently labeled primers (primer sequences are listed in Supplementary  Table 3b ) and genotyped on an ABI 3730 capillary sequencer.
Plasmid constructs. The zebrafish plk4 expression construct was generated by PCR amplification of full-length plk4 from the cDNA of zebrafish embryos at 5 h.p.f. and TA cloning of the resulting fragment into the pGEMTeasy vector (Promega). Full-length human PLK4 was generated by PCR amplification of PLK4 from the IRATp970C1132D plasmid (Source Bioscience). PLK4 c.2811-5C>G, PLK4 c.1299_1303delTAAAG and PLK4 (ALT) were generated from the full-length clone using PCR amplification. The PCR fragments were then shuttled into pDEST-EGFP (LMBP, 4542) and pCDNA3.1-MYCHIS-DEST using Gateway cloning (Life Technologies). Capped plk4 mRNA for injection was transcribed in vitro from linearized DNA using the MessageMachine Transcription kit (Ambion) and purified using the MEGAclear transcription cleanup kit (Ambion).
RT-PCR. RNA was extracted from human primary fibroblast cell lines, an African green monkey fibroblast cell line, the Madin-Darby canine kidney (MDCK) cell line, the Chinese hamster ovary (CHO) cell line, a mouse embryonic fibroblast (MEF) cell line, a chicken B-lymphocyte cell line and zebrafish embryos. Human fetal retina RNA (AmsBio, R1244108-10), total bovine brain RNA (AmsBio, RIB34035), total guinea pig RNA (AmsBio, GR-201), FirstChoice Human Total RNA Survey Panel (Ambion) and Marathon Ready adult retina cDNA (Clontech, 639349) were also purchased as a source of tissue.
Total RNA was isolated using the RNeasy kit (Qiagen) or TRIzol (Life Technologies) according to the manufacturer's instructions. DNA was removed by treatment with DNase I (Qiagen), and cDNA was generated using random oligomer primers and AMV RT (Roche). The RT-PCR primer pairs used in this study are listed in Supplementary Table 3c .
Quantitative RT-PCR for human and zebrafish transcripts was performed using Brilliant II SYBR Green qPCR Master Mix (Stratagene) on the ABI Prism HT7900 Sequence Detection System (Applied Biosciences). The relative expression of target genes in comparison to a control was calculated using the comparative C t method (2 −∆∆Ct ) 49 and represented as the fold induction in mRNA levels. The quantitative PCR primers used are listed in Supplementary Table 3d. Cell culture. Dermal fibroblasts were obtained by skin punch biopsy and were cultured in amnioMAX C-100 complete medium (Life Technologies) and maintained in a 37 °C incubator with 5% CO 2 and 3% O 2 . HeLa cells were obtained from the European Collection of Cell Cultures (93021013) and cultured in DMEM (Life Technologies), 10% FCS, 100 U/ml penicillin and 100 µg/ml streptomycin. hTERT RPE-1 cells were obtained from the American Type Culture Collection (CRL-4000) and cultured in DMEM:F12, 10% FCS, 0.26% sodium bicarbonate, 100 U/ml penicillin and 100 µg/ml streptomycin. All cell lines were routinely tested for mycoplasma. To induce ciliogenesis, cells were incubated in low-serum (0.5% FCS) DMEM for 48 h.
Short interfering RNA (siRNA) oligonucleotides were transfected into primary fibroblasts using Dharmafect 1 (Thermo Fisher) according to the manufacturer's instructions. The oligonucleotide sequences used are listed in Supplementary Table 3e . PLK4 expression vectors were transfected into HeLa cells using Lipofectamine 2000 (Life Technologies) according to the manufacturer's instructions. Where indicated, cells were treated with 10 µM MG132 (Cayman Chemicals) or 1.5 µM staurosporine (Alexis Biochemicals) for 5 h.
Interphase FISH. Nuclear suspensions were generated using standard methods from patient-derived fibroblasts incubated in hypotonic buffer (0.25% KCl) before fixation with 3:1 methanol:acetic acid. FISH was performed using centromere chromosome enumeration (CEP) probes for chromosomes 3, 4, 7, 10, 17 and 18 (Abbot Molecular) labeled in Spectrum Orange, Spectrum Green or Spectrum Aqua in CEP hybridization buffer. Slides were scanned on the GSL-120 Automated Slide Scanner at 60× magnification and analyzed using Cytovision version 7.3.1 (Leica Biosystems).
Immunofluorescence and microscopy. Primary fibroblasts were grown on untreated coverslips. Zebrafish embryo cells were adhered to coverslips coated with poly-l-lysine (Becton Dickinson). Cells were either fixed in methanol (−20 °C) for 7 min or 4% paraformaldehyde (TAAB) in PHEM (25 mM HEPES-NaOH, pH 6.8, 100 mM EGTA, 60 mM PIPES, 2 mM MgCl 2 ) for 15 min. After fixation with paraformaldehyde, cells were permeabilized by npg
